Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Jan 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2025Sell(S)1K$10.02$13K2.9M
Jan 6, 2025Sell(S)941$10.16$10K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-000610) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML